Person

Robert Eckert

Director, Amgen

Current S&P 500 boards
2
Current roles
2
Open-market buys
$497K
Open-market sales
$1.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 18, 2022AMGNSale6,600$249.00$1.6M
Jun 15, 2020UBERBuy15,740$31.60$497K

SEC reporting-owner ID (CIK) 1194256 · all filings on EDGAR